Literature DB >> 1953989

The molecular forms of acetylcholinesterase in cerebrospinal fluid of normal subjects--effect of aging.

J Sirviö1, Z Rakonczay, P Hartikainen, P Kasa, P J Riekkinen.   

Abstract

Acetylcholinesterase (AChE) activity is increased in human cerebrospinal fluid (CSF) during aging. The present study investigated whether the relative amounts of different molecular forms of CSF-AChE are also affected during aging. Thus, the CSF samples of healthy human subjects (age range 20-79 years, n = 23) were analyzed for sedimentation forms of AChE activity. Five different forms of AChe activity were detected in human CSF. The relative amount of tetrameric and dimeric globular forms, which are the main forms of AChE in CSF, were not related with age. Furthermore, the relative amount of monomeric globular and asymmetric forms which are minor forms of AChE in CSF did not seem to be related to age. Since total CSF-AChE activity is increased during aging, it seems to be due to the increased amounts of the tetrameric and dimeric forms of enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953989     DOI: 10.1007/bf01250575

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  12 in total

Review 1.  Cholinesterase and its molecular forms in pathological states.

Authors:  Z Rakonczay
Journal:  Prog Neurobiol       Date:  1988       Impact factor: 11.685

2.  Changes in cerebrospinal fluid associated with dementia.

Authors:  L J Thal
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

Review 3.  Molecular forms of acetylcholinesterase in brain, nerve and muscle: nature, localization and dynamics.

Authors:  S Brimijoin
Journal:  Prog Neurobiol       Date:  1983       Impact factor: 11.685

4.  The molecular forms of cholinesterase and acetylcholinesterase in vertebrates.

Authors:  J Massoulié; S Bon
Journal:  Annu Rev Neurosci       Date:  1982       Impact factor: 12.449

5.  Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study.

Authors:  C Geula; M M Mesulam
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

6.  Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia.

Authors:  S Nakano; T Kato; S Nakamura; M Kameyama
Journal:  J Neurol Sci       Date:  1986-09       Impact factor: 3.181

7.  Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.

Authors:  J R Atack; C May; J A Kaye; A D Kay; S I Rapoport
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

8.  Age-dependence of the solubility fractions of acetylcholinesterase in the cerebral cortex and cerebellum of the rat.

Authors:  J Sirviö; P J Riekkinen; A Hervonen
Journal:  Neurosci Lett       Date:  1989-01-16       Impact factor: 3.046

9.  Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type.

Authors:  L Tune; S Gucker; M Folstein; L Oshida; J T Coyle
Journal:  Ann Neurol       Date:  1985-01       Impact factor: 10.422

10.  Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease.

Authors:  R Elble; E Giacobini; G F Scarsella
Journal:  Arch Neurol       Date:  1987-04
View more
  2 in total

1.  Selected Gamma Aminobutyric Acid (GABA) Esters may Provide Analgesia for Some Central Pain Conditions.

Authors:  Joel S Goldberg
Journal:  Perspect Medicin Chem       Date:  2010-08-03

2.  Low Molecular Weight Opioid Peptide Esters Could be Developed as a New Class of Analgesics.

Authors:  Joel S Goldberg
Journal:  Perspect Medicin Chem       Date:  2011-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.